Repare Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Repare Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 61% to $51,133,000. Profit margin reached -183%. Total operating expenses were $167,357,000.
Profit Margin
| 2017 | 0 | -7.79M | |
|---|---|---|---|
| 2018 | 0 | -14.28M | |
| 2019 | 0 | -27.21M | |
| 2020 | 135K | -53.41M | -39568.15% |
| 2021 | 7.6M | -106.90M | -1406.68% |
| 2022 | 131.83M | -29.04M | -22.03% |
| 2023 | 51.13M | -93.79M | -183.44% |
RPTX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 51.13M | 131.83M | 7.6M | 135K | 0 | 0 | 0 |
Cost of revenue | 131.20M | 4.18M | 3.34M | 1.78M | 968K | 0 | 102K |
Gross profit | -80.07M | 127.64M | 4.25M | -1.65M | -968K | 0 | -102K |
Operating exp. | |||||||
Research and development | 133.59M | 119.06M | 90.04M | 40.09M | 20.99M | 9.90M | 4.40M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 167.35M | 151.62M | 116.26M | 54.43M | 26.37M | 12.82M | 6.17M |
Operating income | -116.22M | -19.79M | -108.66M | -54.30M | -26.37M | -12.82M | -6.17M |
Other income (expenses), net | 13.04M | 5.89M | 74K | -440K | -644K | -1.42M | -1.62M |
Income before tax | -103.17M | -13.9M | -108.58M | -54.74M | -27.02M | -14.24M | -7.79M |
Income tax expense | -9.38M | 15.14M | -1.67M | -1.32M | 195K | 35K | 147K |
Net income | -93.79M | -29.04M | -106.90M | -53.41M | -27.21M | -14.28M | -7.79M |
Earnings per share | |||||||
Basic EPS | -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.9 | -0.49 |
Diluted EPS | -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.9 | -0.49 |
| Data source | Data source | Data source | Data source |